University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment : routine care data from 13 registries in the EuroSpA collaboration

Simple item page
dc.contributor.authorMichelsen, Brigitte
dc.contributor.authorLindström, Ulf
dc.contributor.authorCodreanu, Catalin
dc.contributor.authorCiurea, Adrian
dc.contributor.authorZavada, Jakub
dc.contributor.authorLoft, Anne Gitte
dc.contributor.authorPombo-Suarez, Manuel
dc.contributor.authorOnen, Fatos
dc.contributor.authorKvien, Tore K
dc.contributor.authorRotar, Ziga
dc.contributor.authorSantos, Maria Jose
dc.contributor.authorIannone, Florenzo
dc.contributor.authorHokkanen, Anna-Mari
dc.contributor.authorGudbjornsson, Bjorn
dc.contributor.authorAskling, Johan
dc.contributor.authorIonescu, Ruxandra
dc.contributor.authorNissen, Michael J
dc.contributor.authorPavelka, Karel
dc.contributor.authorSanchez-Piedra, Carlos
dc.contributor.authorAkar, Servet
dc.contributor.authorSexton, Joseph
dc.contributor.authorTomsic, Matija
dc.contributor.authorSantos, Helena
dc.contributor.authorSebastiani, Marco
dc.contributor.authorÖsterlund, Jenny
dc.contributor.authorGeirsson, Arni Jon
dc.contributor.authorMacfarlane, Gary
dc.contributor.authorvan der Horst-Bruinsma, Irene
dc.contributor.authorGeorgiadis, Stylianos
dc.contributor.authorBrahe, Cecilie Heegaard
dc.contributor.authorØrnbjerg, Lykke Midtbøll
dc.contributor.authorHetland, Merete Lund
dc.contributor.authorØstergaard, Mikkel
dc.contributor.institutionUniversity of Aberdeen.Epidemiology Groupen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)en
dc.date.accessioned2020-10-21T16:42:01Z
dc.date.available2020-10-21T16:42:01Z
dc.date.issued2020
dc.descriptionAcknowledgements Thanks to Novartis Pharma AG and IQVIA for supporting the EuroSpA collaboration. Novartis had no influence on the data collection, statistical analyses, manuscript preparation or decision to submit. Contributors The study protocol and analysis plan was drafted by BM, MØ and MLH and revised and approved by all authors. Data analyses were done by BM and draft of the manuscript by BM, MØ, MLH and LØ. All authors have contributed substantially to the acquisition and interpretation of data, revised the manuscript for importantintellectual content and approved the final submitted version. Funding The EuroSpA collaboration was financially supported by Novartis. Novartis had no influence on the data collection, statistical analyses, manuscript preparation or decision to submit. The national registries have received financial support froma range of pharmaceutical companies, including Novartis. These funds are given as unrestricted grants.en
dc.description.statusPeer revieweden
dc.format.extent12
dc.format.extent1117120
dc.identifier178180376
dc.identifier0db33ae5-3c89-4045-ad2d-56d81d6ec826
dc.identifier32950963
dc.identifier85091265627
dc.identifier.citationMichelsen, B, Lindström, U, Codreanu, C, Ciurea, A, Zavada, J, Loft, A G, Pombo-Suarez, M, Onen, F, Kvien, T K, Rotar, Z, Santos, M J, Iannone, F, Hokkanen, A-M, Gudbjornsson, B, Askling, J, Ionescu, R, Nissen, M J, Pavelka, K, Sanchez-Piedra, C, Akar, S, Sexton, J, Tomsic, M, Santos, H, Sebastiani, M, Österlund, J, Geirsson, A J, Macfarlane, G, van der Horst-Bruinsma, I, Georgiadis, S, Brahe, C H, Ørnbjerg, L M, Hetland, M L & Østergaard, M 2020, 'Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment : routine care data from 13 registries in the EuroSpA collaboration', RMD Open, vol. 6, no. 3, e001280. https://doi.org/10.1136/rmdopen-2020-001280en
dc.identifier.doi10.1136/rmdopen-2020-001280
dc.identifier.iss3en
dc.identifier.issn2056-5933
dc.identifier.otherORCID: /0000-0003-2322-3314/work/82378990
dc.identifier.urihttps://hdl.handle.net/2164/15261
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85091265627&partnerID=8YFLogxKen
dc.identifier.vol6en
dc.language.isoeng
dc.relation.ispartofRMD Openen
dc.subjectDMARDs (biologic)en
dc.subjectOutcomes researchen
dc.subjectSpondyloarthritisen
dc.subjectR Medicineen
dc.subjectImmunology and Allergyen
dc.subjectRheumatologyen
dc.subjectImmunologyen
dc.subject.lccRen
dc.titleDrug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment : routine care data from 13 registries in the EuroSpA collaborationen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
e001280.full.pdf
Size:
1.07 MB
Format:
Adobe Portable Document Format
Download

Collections

All research